Further analysis revealed that the AUC of the ratio of CD45+EpCAM+ cells in PBMCs of patients with lung cancer was 0.845, which was slightly higher to that of serum CEA level (0.732) (Figures 3B,C). This evidence concerns the gene EPCAM and lung cancer.